Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma.
Ya-Bing CaoKin Iong ChanGungli XiaoYanqun ChenXibin QiuHu HaoSao Chi MakTongyu LinPublished in: BMC cancer (2019)
Tumor PD-L1 expression and BRAF mutation are associated with poor outcomes in patients with NPC. This study was retrospectively registered in ClinicalTrials.gov (NCT03989297) on 2019-6-18.